NCT06672172View on ClinicalTrials.gov

A Study of HRS-7535 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Diet and Exercise

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

284

Participants

Timeline

Start Date

September 25, 2024

Primary Completion Date

November 15, 2025

Study Completion Date

April 21, 2026

Conditions
Type 2 Diabetes
Interventions
DRUG

HRS-7535 tablet

HRS-7535 tablet; low dose

DRUG

HRS-7535 tablet

HRS-7535 tablet; middle dose

DRUG

HRS-7535 tablet

HRS-7535 tablet; high dose

DRUG

HRS-7535 placebo tablet

HRS-7535 placebo tablet

Trial Locations (1)

100730

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY

NCT06672172 - A Study of HRS-7535 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Diet and Exercise | Biotech Hunter | Biotech Hunter